PPCB

Propanc Biopharma, Inc. - Common Stock

NASDAQ · us_market

Last price

—

Profile

Quote type: EQUITY
Price rows: 0

Last error: numeric field overflow DETAIL: A field with precision 18, scale 6 must round to an absolute value less than 10^12.

AI insight · the why

No AI insight generated yet for this ticker.

No Setup Score available for this ticker yet.

🔍

Company & Price

Price (last 5Y) · orange dots are splits

30d return

—

Historical lean-in setups

since 2020 (DD ≥15%, bounce ≥15%)

30d ATM IV

—

implied volatility

1Y alpha vs sector

—

sector benchmark unavailable

30d realized vol

—%

Drawdown from ATH

—

🏦

Institutions & Smart Money

📂

Deep Dive

Fundamentals

as of 2026-05-31

Valuation

Market Cap$4.15M

Enterprise Value$5.28M

Trailing P/E0.00

Forward P/E—

PEG Ratio—

P/B2.34

P/S—

EV / Revenue—

EV / EBITDA-0.29

Profitability

Gross Margin0.00%

Operating Margin0.00%

Profit Margin0.00%

ROE-126.98%

ROA-62.31%

Revenue Growth (YoY)—

Earnings Growth (YoY)—

Cash & Leverage

Total Cash$443.70K

Total Debt$573.87K

Debt / Equity0.05

Current Ratio2.37

Free Cash Flow$46.03M

Operating Cash Flow$-4.13M

Shareholders

Dividend Yield—

Payout Ratio0.00%

% Held by Insiders14.85%

% Held by Institutions0.81%

Shares Outstanding2.28M

Float1.63M

PPCB

Company & Price

Price (last 5Y) · orange dots are splits

Historical Bottom-Picking Review

Institutions & Smart Money

Deep Dive

Related News

Retail Interest & Short Interest

Fundamentals